Skip to content

Maxavo

Active Private limited companyfounded 2013active for 13 yearsAstridstraat 9A, 9620 ZottegemKBO/BCE: BE 0534.935.895

Lifetime

12 annual accounts with figures on one time axis
peak of €144,902 in 2014
€69,409▲ 134%
lowest -€9,114 in 2022
€34,385▲ 313%
peak of €281,053 in 2025
€281,053▲ 13.9%
€11,097▼ 21.3%
Board1 name since 2013
1 director
Documentsfilings and deeds
30-01-20261 day before the deadline
2025micro format
Gross margin from €29,673 to €69,409Result from €8,319 to €34,385Equity from €246,667 to €281,053Debts from €14,093 to €11,097Cash from €2,807 to €11,992

Key points

from the 2025 annual accounts

Turnover

≈ €150,000 estimated

The micro format states no turnover.

Filings

12 annual accounts since 2014
deadline201520202025

The last five annual accounts were filed 0 to 1 days before the end of the period.

Position in the sector

96.2%

Higher solvency than 93% of companies in human health. The sector median is 63.1%, over 21,373 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,728 companies had the same profile as Maxavo has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,728 companies, not a prediction for Maxavo. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 31-05-2013
  • 186 sharesdeed of 14-06-2013
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0534935895
Company renamed from DR. M. VOORMOLEN to MAXAVO changes role from statutory manager to director · Discharge granted to · General meeting of 16-06-2023 · Gazette deed
First establishment Astridstraat 9, Zottegem
Incorporation Founding capital of €18,600, 186 shares, €12,400 paid up · Founded by · appointed as statutory manager and sole manager · published on 14-06-2013 · Gazette deed
All 21 events

Comparable companies

same main activity, similar in size and age
Company
Maxavo Zottegem €292,149 €69,409 96.2% -
Dr Thomsin Anesthésie Court-Saint-Etienne €303,400 €72,676 82.2% -
Dr. Pia Stevens Chirurg Hasselt €287,507 €70,168 88.3% -
DR. HOMA HOSSEINI Edegem €279,289 €73,203 29.8% -
DOCTEUR Gloria MAVROPOULOS Chaudfontaine €291,879 €76,097 75.4% -
NANG ATTO Tournai €322,861 €74,022 64.9% -
DR. LEEN DE BACKER , MEDISCHE ONCOLOGIE Aalter €271,731 €81,753 54.2% -

These companies have the same main activity as Maxavo: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €272,000 and €323,000, founded between 2012 and 2014.

Official details

Source: KBO
Status
Active since 05-06-2013Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.220.352.7649620 Zottegem, since 11-07-2013
Financial year end
30 June
Peppol
Reachable since 12-08-2025
Company details

Annual accounts to 30-06-2025

€292,149▲ 12.0%
Filing
Filed on 30-01-2026, 1 day before the end of the filing period
Financials

Insights on Maxavo

Maxavo files the micro format. That format states no turnover. The gross margin fell from €144,902 in 2014 to €69,409 in 2025.

The balance sheet grew most in 2020 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Maxavo

What is the company number of Maxavo?
The company number of Maxavo is 0534.935.895. The VAT number is the same number with BE in front: BE 0534.935.895.
Where is Maxavo based?
The registered office is at Astridstraat 9A, 9620 Zottegem.Company details
What does Maxavo do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Maxavo?
Maxavo is a private limited company (BV).
When was Maxavo founded?
Maxavo was founded on 05-06-2013.
Is Maxavo still active?
Yes, Maxavo is an active enterprise in the KBO register.
What is the turnover of Maxavo?
The turnover in financial year 2025 is about €150,000. This figure is estimated from the gross margin of €69,409 and 33 comparable companies (NACE 862). It probably lies between €120,000 and €190,000.Financials
Is Maxavo profitable?
In financial year 2025, Maxavo made a profit of €34,385.
Where can I find the annual accounts of Maxavo?
Maxavo filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Maxavo due?
Maxavo must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.